In 198 out of 457 cases of GC, the expression of KRS was higher in the tumor cells and TAIs(tumor-associated inflammatory cells), including macrophages/monocytes, CD4-positive T cells, and neutrophils, as compared to the normal tissues. This evidence concerns the gene KARS1 and neoplasm.